1. JS06.4.A Intracranial ependymomas of the adult: outcome and response to treatments across molecular subtypes. (5th September 2022) Authors: Bruno, F; Pellerino, A; Pronello, E; Bertero, L; Tampieri, C; Francia Di Celle, P; Mantovani, C; Moro, M; Bartoletti, V; Baciorri, F; Garbossa, D; Soffietti, R; Rudà, R Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS06.7A METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy. (9th September 2021) Authors: Zhu, L; Blanco-Aparicio, C; Bertero, L; Soffietti, R; Weiss, T; Muñoz, J; Sepúlveda, J; Weller, M; Pastor, J; Valiente, M Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS07.4.A Regorafenib in recurrent glioblastoma patients: a multicentric real-life study. (5th September 2022) Authors: Bruno, F; Pellerino, A; Pronello, E; Palmiero, R; Polo, V; Vitaliani, R; Trincia, E; Internò, V; Porta, C; Soffietti, R; Rudà, R Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS08.4.A Analysis of melanoma brain metastasis immune microenvironment through multiplex gene expression profiling. (5th September 2022) Authors: Ricci, A A; Collemi, G; Orlando, G; Tampieri, C; Senetta, R; Pellerino, A; Bruno, F; Melcarne, A; Garbossa, D; Rudà, R; Soffietti, R; Ribero, S; Quaglino, P; Cassoni, P; Bertero, L Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS1.4 Liquid biopsy of the CSF in a series of GBM patients: preliminary results. (6th September 2019) Authors: Rudà, R; Bruno, F; De Bacco, F; Orzan, F; Cassoni, P; Altieri, R; Melcarne, A; Garbossa, D; Boccaccio, C; Soffietti, R Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma <GBM> patients <PTS>. (19th September 2018) Authors: Lombardi, G; de Salvo, G; Rudà, R; Franceschi, E; Eoli, M; Faedi, M; Pace, A; Lolli, I; Rizzato, S; Germano, D; Pasqualetti, F; Farina, M; Magni, G; Bellu, L; Caccese, M; Pambuku, A; Bergo, E; Indraccolo, S; Gardiman, M; Soffietti, R Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OS3.1 IDH-wild type grade II gliomas: a retrospective series of AINO (Italian Association of Neuro-Oncology). (19th September 2018) Authors: Bruno, F; Silvani, A; Ius, T; Bello, L; Minniti, G; Pace, A; Lombardi, G; Soffietti, R; Rudà, R Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OS7.3 Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients. (6th September 2019) Authors: Lombardi, G; Del Bianco, P; Brandes, A; Eoli, M; Rudà, R; Ibrahim, T; Lolli, I; Pace, A; Daniele, B; Pasqualetti, F; Rizzato, S; Bergo, E; Caccese, M; Padovan, M; Soffietti, R; De Salvo, G; Zagonel, V Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P01.054 Patterns of first tumor progression and impact on survival of salvage therapies in low-grade gliomas following initial chemotherapy with temozolomide. (19th September 2018) Authors: Pellerino, A; Rudà, R; Pace, A; Carapella, C; Dealis, C; Caroli, M; Faedi, M; Bello, L; Soffietti, R Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P01.116 Treatment with Dabrafenib in a patient with BRAF mutated recurrent ganglioglioma. (19th September 2018) Authors: Pasqualetti, F; Gonnelli, A; Molinari, A; Cantarella, M; Mattioni, R; Baldaccini, D; Grazzini, M; Paiar, F; Rudà, R; Soffietti, R Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗